Research and Clinical Trials

Richard Vile, Ph.D., is leading research into genetically engineered viruses called oncolytic viruses for cancer treatment at Mayo Clinic.

After receiving CAR-T cell therapy at Mayo Clinic, Welsh-born John Cadwallader achieved remission and found new hope. He now receives care in the U.K. and is monitored by Mayo in the U.S. and London.

After undergoing genetic screening as part of a research study, Tammy LeDoux learned she had Lynch syndrome, which put her at high risk of cancer.

Mayo Clinic launched the Caregiver Support Program to help family caregivers in December 2021. This is its origin story.

Mayo Clinic research could lead to a screening test for endometrial cancer that analyzes vaginal fluid collected with a tampon.

Dr. Rick Bold, site deputy director for Mayo Clinic Comprehensive Cancer Center in Arizona, discusses breaking down barriers that stand in the way of cancer care.

Dr. Sumera Ilyas discusses the recent advances researchers have made in diagnosing, staging and treating bile duct cancer.

Learn about CAR-T cell therapy and research at Mayo Clinic to reduce its side effects and expand its use beyond blood cancers.

They identified a cell-signaling protein that drives pancreatic cancer cell growth that could be a potential therapeutic target.

Read about cancer research conducted by scientists at Mayo Clinic Comprehensive Cancer Center over the past year.